16. Novel Therapies

Experience novel therapies in IBD, and of clinical trials used to pilot their introduction


Full content only available after log-in


16.1.  Understands the different types of evidence – clinical trial / cohort study / systematic review etc.

16.2.  Knows the evidence that supports the use of currently unlicensed therapies in IBD


        
 
Topic:
Programme Phase:
Content Format:


Topic 16.1 : Educational update

How to set-up a successful translational IBD unit – Providing the frame for future discovery

B Siegmund

ECCO 2017 Barcelona Congress

Webcast + PPT
 

Topic 16.1 : Educational update

Omics analysis – Can we see the forest for the trees

J Barrett

ECCO 2017 Barcelona Congress

Webcast + PPT
 

Topic 16.1 : Educational update

Recreating the intestine ex vivo - Where are we on the way to the artificial gut (organoids, etc.)

A Salas

ECCO 2017 Barcelona Congress

Webcast + PPT
 

Topic 16.2 : State of the art

Positioning of the new molecules in practice

B Feagan

ECCO 2015 Barcelona Congress

Webcast
 

Topic 16.2 : State of the art

The science which will impact our IBD clinic

M Abreu

ECCO 2015 Barcelona Congress

Webcast
 

Topic 16.2 : State of the art

Haematopoietic stem cell transplantation

A Salas, E Ricart

ECCO 2016 Amsterdam Congress

Webcast
 

Topic 16.2 : State of the art

Immune cell manipulation

G Lord, M Allez

ECCO 2016 Amsterdam Congress

Webcast
 

Topic 16.2 : State of the art

Future strategies to change the flora

H Sokol

ECCO 2016 Amsterdam Congress

Webcast
 

Topic 16.2 : State of the art

Placing new molecules in the treatment pathway

G Rogler

ECCO 2017 Barcelona Congress

Webcast + PPT
 

Topic 16.2 : State of the art

JAK-inhibitors

S Vermeire

ECCO 2017 Barcelona Congress

Webcast + PPT